title: Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss.
authors.affiliation: LifeQuest Centre for Reproductive; Medicine and Mt. Sinai Hospital, Toronto, Ontario, Canada (Clark, Spitzer) University of Toronto, LifeQuest; Centre for Reproductive Medicine and Mt. Sinai Hospital, Toronto, Ontario, Canada (Laskin) McMaster Medical Centre, Hamilton,Ontario Canada (Crowther, Ginsberg).
authors.forename: Christine A
authors.initials: CA
authors.lastname: Clark
authors.forename: Karen A
authors.initials: KA
authors.lastname: Spitzer
authors.forename: Carl A
authors.initials: CA
authors.lastname: Laskin
authors.forename: Mark R
authors.initials: MR
authors.lastname: Crowther
authors.forename: Jeff S
authors.initials: JS
authors.lastname: Ginsberg
mesh_terms: D000026:Abortion, Habitual / Q000453:epidemiology / Q000276:immunology*; D017153:Antibodies, Anticardiolipin / Q000032:analysis*; D000925:Anticoagulants / Q000008:administration & dosage; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006493:Heparin / Q000008:administration & dosage*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D050498:Live Birth; D015201:Meta-Analysis as Topic; D011247:Pregnancy
chemical_list: D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D001241:Aspirin